lunedì, Giugno 24, 2024

The dark side of sulfur metabolism: are neurodegeneration and inflammatory bowel diseases lying above?

Neurodegenerative diseases (NDDs), which have no known cures and...

Gli effetti dello zucchero sulla salute pubblica: diabete, malattia cardiache ed ora anche renali

Eccesso di zuccheri e salute pubblica Le malattie non trasmissibili...

La prima dimostrazione che PARP1 modifica anche il DNA: salta il dogma resistito per sessant’anni

Il compito dell'enzima PARP1 è la sorveglianza del genoma:...

Breast cancer: fatty menopause is a dangerous cellular activaTOR

Scientists have long known that excess body weight increases women’s risks of ER-positive breast cancer after menopause, but the specific metabolic pathways and genetic processes that trigger the disease have been less clear. Pathway-preferential estrogens are chemically modified to reduce their potential adverse effects on reproductive and breast tissues. Now, scientists at the University of Illinois have found that free fatty acids in the blood appear to boost proliferation and growth of breast cancer cells. The finding could help explain obese women’s elevated risk of developing breast cancer after menopause. The findings were published today by the journal Cancer Research. To explore associations of body mass index with breast cancer risk, researchers obtained blood samples from the Susan G. Komen Tissue Bank and compared those of healthy women with the samples of women who were healthy at the Baltimore study’s outset but later developed breast cancer, looking for the presence of various metabolites, biomarkers of inflammation and cancer-related proteins

Women who developed breast cancer – and women who were overweight or obese – had significantly higher blood concentrations of five free fatty acids and glycerol, which are released as byproducts when fat tissue breaks down triglycerides. The team analyzed additional blood samples from 37 nonobese and 63 obese postmenopausal women, as well as samples from 21 postmenopausal women who previously were obese but lost weight. All of the women were participants in the Midlife Women’s Health Study, a long-term study of women ages 45-64 in the Baltimore area. They found that obese women’s levels of free fatty acids were significantly higher; however, blood levels of all the fatty acids fell significantly in women who were obese at the outset of the Baltimore study but later lost a significant amount of weight. To explore the impact that obesityhas on ER-positive cancer cells, the researchers treated several lines of primary tumor and metastatic cancer cells with the blood of obese women.

They found that the cancer cells became more viable and multiplied in direct correlation with blood fatty acid levels. Exposure to the fatty acids in the women’s blood also appeared to make the disease more aggressive. One line of primary tumor cells became more motile and an enzyme pathway that regulates cell growth, proliferation and survival in a metastatic cell line was activated, according to the study. The greater the cells’ level of exposure to the fatty acids, the more pronounced was the effect on this enzyme pathway, known as mTOR pathway. This cellular transduction pathway is involved in protein synthesis regulated by growth factors like EGF, insulin, IGF-1 and FGF-2, which are all important for tumor cell proliferation. In previous studies, the team found that modifying the mTOR pathway’s interaction with ER-positive cells through a pathway-preferential estrogen compound elicited favorable responses in certain genes, such as preventing fat accumulation in mouse livers, without adversely affecting reproductive tissues.

To examine how this estrogen would affect gene expressionin the current study, they treated one group of breast cancer cells with oleic acid and another group of cells with a combination of oleic acid and the estrogen hormone (estradiol). Oleic acid increased the expression of genes involved in cell proliferation and down-regulated about 500 genes, including those involved in fatty acid metabolism and cell adhesion. However, these effects were greatly reduced in cells that were treated with the estrogen plus oleic acid. This pathway the Women’s Health, Hormones and Nutrition Lab, explained: “When taken up by estrogen-receptor positive breast cancer cells, these fatty acids activated pathways that increased tumor growth, survival and cell proliferation. Our clinical data provide a more complete understanding of the mechanisms that connect obesity with breast cancer, and provide an opportunity to assess the ability of pathway-preferential estrogens to decrease breast cancer risk in obese postmenopausal women”.

  • Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.

Scientific references

Madak-Erdogan Z et al. Cancer Res. 2019 Mar 12.

Marcial-Medina C et al. Endocr Connect. 2019 Feb 1.

Quiroga PL et al. Nutr Cancer 2018; 70(7):1137-1144.

Huang LH et al. BMC Cancer. 2017 Dec 28; 17(1):8.

Latest

The dark side of sulfur metabolism: are neurodegeneration and inflammatory bowel diseases lying above?

Neurodegenerative diseases (NDDs), which have no known cures and...

Gli effetti dello zucchero sulla salute pubblica: diabete, malattia cardiache ed ora anche renali

Eccesso di zuccheri e salute pubblica Le malattie non trasmissibili...

La prima dimostrazione che PARP1 modifica anche il DNA: salta il dogma resistito per sessant’anni

Il compito dell'enzima PARP1 è la sorveglianza del genoma:...

Hormones, genetics and food choices: the complex yet easy picture behind acne

On the origins of acne Acne vulgaris is a chronic...

Newsletter

Don't miss

The dark side of sulfur metabolism: are neurodegeneration and inflammatory bowel diseases lying above?

Neurodegenerative diseases (NDDs), which have no known cures and...

Gli effetti dello zucchero sulla salute pubblica: diabete, malattia cardiache ed ora anche renali

Eccesso di zuccheri e salute pubblica Le malattie non trasmissibili...

La prima dimostrazione che PARP1 modifica anche il DNA: salta il dogma resistito per sessant’anni

Il compito dell'enzima PARP1 è la sorveglianza del genoma:...

Hormones, genetics and food choices: the complex yet easy picture behind acne

On the origins of acne Acne vulgaris is a chronic...
Dott. Gianfrancesco Cormaci
Dott. Gianfrancesco Cormaci
Laurea in Medicina e Chirurgia nel 1998, specialista in Biochimica Clinica dal 2002, ha conseguito dottorato in Neurobiologia nel 2006. Ex-ricercatore, ha trascorso 5 anni negli USA alle dipendenze dell' NIH/NIDA e poi della Johns Hopkins University. Guardia medica presso la casa di Cura Sant'Agata a Catania. In libera professione, si occupa di Medicina Preventiva personalizzata e intolleranze alimentari. Detentore di un brevetto per la fabbricazione di sfarinati gluten-free a partire da regolare farina di grano. Responsabile della sezione R&D della CoFood s.r.l. per la ricerca e sviluppo di nuovi prodotti alimentari, inclusi quelli a fini medici speciali.

Medicina di genere (3): le differenze per diabete, depressione e cardiopatie

La depressione è associata a un rischio significativamente maggiore di sviluppare diabete di tipo 2 (T2D) e malattie cardiovascolari (CVD). La stima generale è...

Il ruolo dei grassi nel sistema immunitario: chi ha detto che servono solo all’energia?

Quando si parla di grassi, li si associa convenzionalmente al sovrappeso, all’obesità ed alla salute cardiovascolare. Gli sportivi sanno bene che i grassi, sottoforma...

Immagine corporea e Instagram: un intreccio fra Influencers, società, benessere mentale e salute pubblica

L’uso dei social media (come Facebook, Instagram, Twitter) è cresciuto costantemente e continuamente negli ultimi dieci anni. Attualmente, l’83% della popolazione australiana ha account...

Questo si chiuderà in 20 secondi